Toronto Western Hospital - University Health Network
Welcome,         Profile    Billing    Logout  
 5 Trials 
3 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pereira, Vitor Mendes
NCT06165341: Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)

Recruiting
3
50
Europe, Canada, US
Fazirsiran Injection, TAK-999, ARO-AAT, ADS-001, Placebo
Takeda
Alpha1-Antitrypsin Deficiency
08/28
08/28
NCT05677971: Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein

Recruiting
3
160
Europe, Canada, US, RoW
Fazirsiran Injection, TAK-999, ARO-AAT, ADS-001, Placebo, Sodium chloride
Takeda, Takeda Development Center Americas, Inc.
Alpha1-Antitrypsin Deficiency
03/27
03/29
EVOLVE, NCT04195568: Evaluation of Safety and Effectiveness of Stryker Surpass Evolve™ Flow Diverter System

Active, not recruiting
N/A
248
Canada, US, RoW
Surpass Evolve Flow Diverter System
Stryker Neurovascular
Aneurysm, Intracranial
12/24
09/28
Rosenblat, Joshua D
No trials found
Kaczmarek, Erica
No trials found

Download Options